All In Biotech

Free tool

FAERS Monitor: Simponi Aria

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125433 or its brand name (Simponi Aria, Golimumab). Reports on generic versions are filed under their own applications.

Reports

12,593

Serious

9,544

76% of reports

Hospitalization

4,405

Death reported

2,708

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,916
  • off label use2,949
  • pain2,949
  • rheumatoid arthritis2,927
  • fatigue2,768
  • alopecia2,587
  • rash2,513
  • systemic lupus erythematosus2,509
  • abdominal discomfort2,482
  • pemphigus2,476
  • glossodynia2,470
  • hypersensitivity2,434
  • hand deformity2,409
  • infusion related reaction2,350
  • wound2,328

Reports by year received

View as table
YearReports
2009124
2010170
2011304
2012243
2013200
2014124
2015594
2016405
2017590
2018752
2019768
2020775
20211,050
20221,243
20231,034
20241,785
20251,676
2026756

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,566 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal2,476412.1395.8814,753
hand deformitySignal2,409375.4360.5734,736
glossodyniaSignal2,470207.0199.3450,836
woundSignal2,328151.6145.9319,687
systemic lupus erythematosusSignal2,509127.0122.4291,781
infusion related reactionSignal2,35061.459.1134,937
rheumatoid arthritisSignal2,92744.242.8120,935
abdominal discomfortSignal2,48225.124.256,936
alopeciaSignal2,58722.321.552,362
hypersensitivitySignal2,43422.221.448,989
rashSignal2,5139.79.319,847
painSignal2,9498.17.818,665
fatigueSignal2,7686.05.811,806
off label useSignal2,9495.65.511,704
drug ineffectiveSignal3,9165.04.813,223

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.